Bot Detector
Download FREE Sample Issue or Article
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome

Author(s):  Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III

Issue:  May/Jun 2010 - Pain Management
View All Articles in Issue

Abstract:  Pain caused by disorders of movement is often chronic and severe and may not be alleviated by commercially available medications. In such cases, the use of a compounded formulation can provide relief, either as sole therapy or as part of a combination treatment regimen. In this report, we review the effects of compounded analgesic preparations on chronic severe pain like that produced by arthritis, neuropathy, or postpolio syndrome. Case reports are included, formulations are presented, and two patients (one of whom, RFM III, is a coauthor of this paper) with a painful movement disorder describe their response to custom compounded therapy.

Related Keywords: Scott Brown, RPh, Brian Erickson, MD, George Muller, RPh, Susan J. Bryant-Snure, MD, Richard F. Mestayer III, MD, formulations, movement disorders, arthritis, osteoarthritis, rheumatic disorders, neuropathy, neuropathic pain, postpolio syndrome, polio, nerve pain, chronic pain, analgesic, analgesia, pain management, pain control, transdermal gel, topical preparations, intranasal administration, nasal sprays, oxytocin, hydrocodone, amitriptyline, gabapentin, ketoprofen, degenerative disk disease, inflammatory disorders, inflammation, back pain, joint pain, baclofen, clonidine, lidocaine, case reports, spinal pain, substance abuse, addiction, opioids


Printer-Friendly Version

Download in electronic PDF format for $65

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III May/Jun 2010 182-192 Buy
Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis Muller George, Young Thomas W, Reina Rachel, Caldwell Delmar R Jan/Feb 2010 40-45 Buy
Update on Managing Neuropathic Pain McNulty Jack P, Muller George May/Jun 2009 182-190 Buy
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso Jul/Aug 2014 278-286 Buy
Topical Medications for Orofacial Neuropathic Pain Bramwell Bethany L May/Jun 2010 200-203 Buy
Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial Rabi Joseph, Minori Joshua, Abad Hasan, Lee Ray, Gittler Michelle Nov/Dec 2016 517-520 Buy
Levorphanol, Methadone, and the Management of Intractable Chronic Pain: An Interview with Kerry Schmidt, BA, MBA; Jack P. McNulty, MD, FACP; and George B. Muller, RPh Vail Jane Jan/Feb 2006 9-11 Buy
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Rabi Joseph Mar/Apr 2016 107-113 Buy
Stability of Tranexamic Acid in 0.9% Sodium Chloride, Stored in Type 1 Glass Vials and Ethylene/Propylene Copolymer Plastic Containers McCluskey Susan V, Sztajnkrycer Matthew D, Jenkins Donald A, Zietlow Scott P, Berns Kathleen S, Park Myung S Sep/Oct 2014 432-437 Buy
A Brief Survey on Prescriber Beliefs Regarding Compounded Topical Pain Medications Warner Meredith, Tuder Dmitry May/Jun 2014 182-188 Buy
Particle Measuring Systems - USP <797> Environmental Monitoring Solutions